Health
PD-L1: A Therapeutic Target for Malignant Melanomas in Dogs – Technology Networks
Scientists have shown that PD-L1 is a potential anti-cancer therapy target for the treatment of metastasized oral malignant melanoma in dogs.
Scientists have shown that the biological molecule PD-L1 is a potential target for the treatment of metastasized oral malignant melanoma in dogs.
There are a number of cancers that affect dogs, but there are far fewer diagnosis and treatment options for these canine cancers. However, as dogs and humans are both mammals, it is likely that strategies and treatments for cancers in humans can be used for canine cancer, with minor modifications.
A team of scientists, including Associate Professor Satoru…
-
Noosa News23 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business24 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Noosa News19 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Business22 hours agoEverything you need to know about the Coles dividend